Lockman, Shahin
- Harvard T.H. Chan School of Public Health · Microbiology & Immunology (NIH department code)
- Brigham and Women's Hospital (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,625
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Microbiology & Immunology
NIH Funding · FY2023
Linked Award Amount
$2.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#3,625
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Lockman, Shahin as a PI. Multi-PI records show the full award amount for context.
- 5UM1AI069456-17UM1Contact PIBotswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTUHarvard T.H. Chan School of Public Health · Microbiology & Immunology (NIH department code)$1.9Maward amount
- 5K24AI131928-07K24Contact PIMentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART$188.7Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Lockman, Shahin as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardHarvard T.H. Chan School of Public Health
- 2007Multi-Institutional ResearchAwards at 2 institutions
- 2009$500K Cumulative Funding
- 2010$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #3117
- 2021Entered Top 25% NationallyRanked #3117
- 2022$5M Cumulative Funding